Spain · Delayed Price · Currency is EUR BME:YCPS Statistics
Total Valuation
BME:YCPS has a market cap or net worth of EUR 938.16 million. The enterprise value is 1.65 billion.
| Market Cap | 938.16M |
| Enterprise Value | 1.65B |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | Dec 1, 2025 |
Share Statistics
BME:YCPS has 127.64 million shares outstanding. The number of shares has increased by 20.15% in one year.
| Current Share Class | 127.64M |
| Shares Outstanding | 127.64M |
| Shares Change (YoY) | +20.15% |
| Shares Change (QoQ) | +4.34% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
The trailing PE ratio is 8.20.
| Price/FFO Ratio | n/a |
| Price/AFFO Ratio | n/a |
| PE Ratio | 8.20 |
| Forward PE | n/a |
| PS Ratio | 6.12 |
| PB Ratio | 0.96 |
| P/TBV Ratio | 1.04 |
| P/FCF Ratio | 11.74 |
| P/OCF Ratio | 11.64 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 16.63, with an EV/FCF ratio of 20.72.
| EV / Earnings | 14.77 |
| EV / Sales | 10.80 |
| EV / EBITDA | 16.63 |
| EV / EBIT | 16.65 |
| EV / FCF | 20.72 |
Financial Position
The company has a current ratio of 0.42, with a Debt / Equity ratio of 0.73.
| Current Ratio | 0.42 |
| Quick Ratio | 0.42 |
| Debt / Equity | 0.73 |
| Debt / EBITDA | 7.12 |
| Debt / FCF | 8.87 |
| Interest Coverage | 3.18 |
Financial Efficiency
Return on equity (ROE) is 13.37% and return on invested capital (ROIC) is 4.23%.
| Return on Equity (ROE) | 13.37% |
| Return on Assets (ROA) | 3.87% |
| Return on Invested Capital (ROIC) | 4.23% |
| Return on Capital Employed (ROCE) | 6.06% |
| Revenue Per Employee | 3.48M |
| Profits Per Employee | 2.55M |
| Employee Count | 47 |
| Asset Turnover | 0.10 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BME:YCPS has paid 674,000 in taxes.
| Income Tax | 674,000 |
| Effective Tax Rate | 0.56% |
Stock Price Statistics
The stock price has increased by +5.76% in the last 52 weeks. The beta is 0.08, so BME:YCPS's price volatility has been lower than the market average.
| Beta (5Y) | 0.08 |
| 52-Week Price Change | +5.76% |
| 50-Day Moving Average | 7.35 |
| 200-Day Moving Average | 7.15 |
| Relative Strength Index (RSI) | 56.31 |
| Average Volume (20 Days) | 42 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BME:YCPS had revenue of EUR 153.18 million and earned 112.02 million in profits. Earnings per share was 0.90.
| Revenue | 153.18M |
| Gross Profit | 153.18M |
| Operating Income | 99.42M |
| Pretax Income | 120.35M |
| Net Income | 112.02M |
| EBITDA | 99.50M |
| EBIT | 99.42M |
| Earnings Per Share (EPS) | 0.90 |
Balance Sheet
The company has 62.20 million in cash and 708.28 million in debt, giving a net cash position of -646.08 million or -5.06 per share.
| Cash & Cash Equivalents | 62.20M |
| Total Debt | 708.28M |
| Net Cash | -646.08M |
| Net Cash Per Share | -5.06 |
| Equity (Book Value) | 975.07M |
| Book Value Per Share | 7.08 |
| Working Capital | -103.25M |
Cash Flow
In the last 12 months, operating cash flow was 80.59 million and capital expenditures -714,000, giving a free cash flow of 79.88 million.
| Operating Cash Flow | 80.59M |
| Capital Expenditures | -714,000 |
| Free Cash Flow | 79.88M |
| FCF Per Share | 0.63 |
Margins
Gross margin is 100.00%, with operating and profit margins of 64.91% and 73.13%.
| Gross Margin | 100.00% |
| Operating Margin | 64.91% |
| Pretax Margin | 78.57% |
| Profit Margin | 73.13% |
| EBITDA Margin | 64.95% |
| EBIT Margin | 64.91% |
| FCF Margin | 52.15% |
Dividends & Yields
This stock pays an annual dividend of 0.83, which amounts to a dividend yield of 11.36%.
| Dividend Per Share | 0.83 |
| Dividend Yield | 11.36% |
| Dividend Growth (YoY) | 187.66% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 96.02% |
| Buyback Yield | -20.15% |
| Shareholder Yield | -8.80% |
| Earnings Yield | 11.94% |
| FCF Yield | 8.51% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |